ClinicalTrials.gg
Drug

Avatrombopag clinical trials

Also written E5501, Doptelet and AKR-501.

studies test it
52
open now
13
in phase 3
14
first study started
2007

How each study uses avatrombopag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the avatrombopag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 May 2018 · DOPTELET · NDA 210238 (FDA, Drugs@FDA)
European Union
20 Jun 2019 · Doptelet · EMEA/H/C/004722 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Avatrombopag
31
Avatrombopag maleate
4
Avatrombopag 20 mg Oral Tablet
4
Avatrombopag Oral Tablet
2
avatrombopag (lower baseline platelet count)
2

Brand

Doptelet
8

Development codes

E5501
12
AKR-501
3
YM477
3
AS 1670542
1

Studies by the year they started

52 studies that test it; most in 2021 (10)

Studies that test avatrombopag, by start year
YearStudies
20072
20091
20103
20113
20123
20133
20142
20161
20182
20202
202110
20229
20233
20243
20253
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
23
Phase 3
14
Phase 4
5
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 27

Eisai Inc. (16) · Institute of Hematology & Blood Diseases Hospital, China (9) · Sobi, Inc. (6) · Peking Union Medical College Hospital (3) · Eisai Co., Ltd. (2) · Hanny Al-Samkari, MD (1) · Anhui Provincial Cancer Hospital (1) · University of Virginia (1)

Often tested with

Tested in the same studies.

Tretinoin (1) · Rituximab (1) · Platelet Transfusion (1) · Medication (1)

Studies

Open first, then newest update. How each study uses avatrombopag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 52

See all 52 studies that test avatrombopag →

Given beside what is tested · 1 — avatrombopag is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call avatrombopag · ClinicalTrials.gg INT005355

  • MeSH (NLM) C533238avatrombopagConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3H8GSZ4SQLAVATROMBOPAGConfirmed FDA, NLM, Wikidata
  • RxNorm 2045726One source FDA
  • Wikidata Q27257213avatrombopagConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C150559AvatrombopagOne source FDA
  • DrugBank DB11995One source Wikidata

Also registered as avatrombopag maleate (UNII GDW7M2P1IS · RxNorm 2045727).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.